Segment Information (Tables)

3 Months Ended

Sep. 30, 2013

Schedule of Segment Performance Measures

Three Months Ended September 30, 2013 and 2012:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2013
Net sales	$	38,694	$	48,424	$	42,143	$	-		$	129,261
Gross profit		11,141		15,262		7,331		-			33,734
Income before income taxes		5,535		11,004		3,302		(2,267	)		17,574

2012
Net sales	$	26,409	$	40,608	$	44,731	$	-		$	111,748
Gross profit		8,103		6,576		6,826		-			21,505
Income before income taxes		3,119		2,553		3,085		(1,135	)		7,622

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details